Rebaudioside M

C[C@]12[C@@]3([H])[C@@](C4)(CC[C@]1([H])[C@@](C)(CCC2)C(O[C@H]5[C@@H]([C@H]([C@H](O)[C@@H](CO)O5)O[C@]6([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]6O)CO)O[C@]7([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)CO)=O)C[C@@](C4=C)(O[C@@]8([H])[C@@H]([C@H]([C@H](O)[C@@H](CO)O8)O[C@]9([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]9O)CO)O[C@]%10([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]%10O)CO)CC3

[1]Prakash I, et al. Development of Next Generation Stevia Sweetener: Rebaudioside M. Foods. 2014 Feb 27;3 (1) :162-175.|[2]Xiaoqiang W, et al. Fusion glycosyltransferase design for enhanced conversion of rebaudioside A into rebaudioside M in cascade. Molecular Catalysis. 2023 Aug, 547: 113317. |[3]Jeppesen PB, et al. Stevioside acts directly on pancreatic beta cells to secrete insulin: actions independent of cyclic adenosine monophosphate and adenosine triphosphate-sensitive K+-channel activity. Metabolism. 2000 Feb;49 (2) :208-14. |[4]Jan S A, et al. The anti-diabetic activities of natural sweetener plant Stevia: an updated review[J]. SN Applied Sciences, 2021, 3: 1-6.|[5]Chakraborty R, et al. Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications[J]. Journal of Integrative Medicine, 2021, 19 (6) : 478-492.|[6]Iatridis N, et al. Anti-Cancer Properties of Stevia rebaudiana; More than a Sweetener. Molecules. 2022 Feb 17;27 (4) :1362.